Publications by authors named "Filip de Vos"

Claim this Profile
A
Adult ependymoma: results from the Dutch Brain Tumour Registry on primary treatment and survival.
Vincent K Y Ho, Johanna M M Gijtenbeek, Sybren L N Maas, Walter Taal, Myra E van Linde, Filip Y F de Vos

J Neurooncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab for symptomatic cerebral radiation necrosis after radiation of high-grade glioma or brain metastases - when and for whom?
Lente L Kroon, Edith M T Dieleman, Vera C Keil, Marit van Barreveld, Marcel G W Dijkgraaf, Maaike J Vos, Filip Y F L de Vos

Neurooncol Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy in adult patients with pilocytic astrocytoma: a retrospective multicenter cohort study.
Laura van den Berg, Joyce Wilbers, Filip Y F L de Vos, Mathilde C M van Kouwenhoven, Antoinette Y N Schouten-van Meeteren

J Neurooncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole genome sequencing-based analysis of genetic predisposition to adult glioblastoma.
Mark P van Opijnen, Devin R van Valkengoed, Joep de Ligt, Filip Y F de Vos, Marike L D Broekman

NPJ Genom Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a definition of an existential approach in cancer patients: a co-produced scoping review.
Anouk M de Sain, Carla Ruis, Margot L Zomers, Marjon E G Ten Hoor-Suykerbuyk, Theo Kuunders, Filip Y F L de Vos

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timely integration of palliative care into oncology in hospitals in the Netherlands: a feasibility study.
Carly S Heipon, Linda Brom, Wendy M van der Deure, Irene Dingemans, Olaf P Geerse, Filip Y F L de Vos

BMC Health Serv Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy?
Bernies van der Hiel, Wouter V Vogel, Alfons J M van den Eertwegh, Carmen A Vlahu, Filip Y F L de Vos

Clin Nucl Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic parameters on baseline and early [F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma.
Bernies van der Hiel, Berlinda J de Wit-van der Veen, Alfons J M van den Eertwegh, Wouter V Vogel, Marcel P M Stokkel, Filip Y F L de Vos

EJNMMI Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Work-related experiences and unmet needs of patients with a malignant glioma and relevant professionals: the BrainWork study.
Amber Daniëlle Zegers, Pieter Coenen, Amy Heeren, Nadia Takke, Hilko Ardon, Filip de Vos

J Cancer Surviv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Transmural collaboration in palliative care: a feasibility study into structured transfer of care for acutely hospitalized patients].
Tamara van Schaik, Filip Y F de Vos, Toosje A C H Valkenburg, Everlien de Graaf, Saskia C C M Teunissen

Ned Tijdschr Geneeskd· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent glioblastoma in national guidelines on the diagnosis and treatment of gliomas: A matter of European practice variation.
Mark P van Opijnen, Rob J A Nabuurs, Filip Y F de Vos, Mohini T R Ramsoedh, Joost J C Verhoeff

Brain Spine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.
Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, Filip de Vos, Ahmed Idbaih

Neuro Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximizing Treatment Opportunities: Assessing Protocol Waivers' Impact on Safety and Outcome in the Drug Rediscovery Protocol.
Jade M van Berge Henegouwen, Laurien J Zeverijn, Birgit S Geurts, Louisa R Hoes, Hanneke van der Wijngaart, Filip Y F de Vos

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology.
Mark P van Opijnen, Filip Y F de Vos, Edwin Cuppen, Marjolein Geurts, Sybren L N Maas

Med Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and on Treatment Biodistribution Variability of 18 F-FLT Uptake in Patients With Advanced Melanoma: Brief Communication.
Bernies van der Hiel, Else A Aalbersberg, Alfons J M van den Eertwegh, Jitha Fischer, Ronald Boellaard, Filip Y F L de Vos

Clin Nucl Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Differentiation between Progressive Disease and Treatment-Induced Effects with Perfusion-Weighted Arterial Spin-Labeling in High-Grade Gliomas.
Christina Maria Flies, Tom Jan Snijders, Beverly Iendra De Leeuw, Emiel Alexander van Maren, Bart Jean Pieter Kersten, Filip Yves Francine De Vos

AJNR Am J Neuroradiol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of Lu-DOTA-CC-PSMA following a unified "Click Chemistry" protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals.
Xiaobei Zheng, Shuai Xue, Zhongqi Zhao, Shuxin Jin, Shuhua He, Filip De Vos

EJNMMI Radiopharm Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole genome sequencing in (recurrent) glioblastoma: challenges related to informed consent procedures and data sharing.
Mira C Hasner, Mark P van Opijnen, Filip Y F de Vos, Edwin Cuppen, Marike L D Broekman

Acta Neurochir (Wien)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Ilse A C Spiekman, Birgit S Geurts, Laurien J Zeverijn, Gijs F de Wit, Vincent van der Noort, Filip Y F L de Vos

Oncologist· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused Ultrasound-Enhanced Liquid Biopsy: A Promising Diagnostic Tool for Brain Tumor Patients.
Akke Bakker, Anna E Ixkes, Hema Venugopal, Mario G Ries, Nathalie S M Lak, Filip Y F L de Vos

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?
Bernies van der Hiel, Else A Aalbersberg, Alfons J M van den Eertwegh, Linda J de Wit-van der Veen, Marcel P M Stokkel, Filip Y F L de Vos

Clin Nucl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
Mark P van Opijnen, Marike L D Broekman, Edwin Cuppen, Hendrikus J Dubbink, Arja Ter Elst, Filip Y F de Vos

J Neurooncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Adverse Outcomes of Shared Decision Making about Palliative Cancer Treatment: A Secondary Analysis of a Randomized Trial.
Loïs F van de Water, Danique W Bos-van den Hoek, Steven C Kuijper, Hanneke W M van Laarhoven, Geert-Jan Creemers, Filip Y F de Vos

Med Decis Making· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Jaap C Reijneveld, Abigirl Machingura, Corneel Coens, Martin J B Taphoorn, Walter Taal, Filip Y F de Vos

Eur J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice variation in re-resection for recurrent glioblastoma: A nationwide survey among Dutch neuro-oncology specialists.
Mark P van Opijnen, Filip Y F de Vos, Rob J A Nabuurs, Tom J Snijders, Rishi D S Nandoe Tewarie

Neurooncol Pract· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis